Kelsey Moody
Amministratore Delegato presso Antoxerene, Inc.
Profilo
Kelsey Moody is the founder and Chief Executive Officer of Auctus Biologicos, Inc., which was founded in 2018.
He is also currently the Chief Executive Officer of Antoxerene, Inc., Ichor Therapeutics, Inc., and President & Director of Lysoclear, Inc. Additionally, he serves as a Scientific Advisor at Methuselah Capital Management LLC.
Posizioni attive di Kelsey Moody
Società | Posizione | Inizio |
---|---|---|
Antoxerene, Inc.
Antoxerene, Inc. BiotechnologyHealth Technology Antoxerene, Inc. operates as a pharmaceutical company. It develops small molecule senolytic drugs for pathways of aging. The company was incorporated in 2016 and is headquartered in Lafayette, NY. | Amministratore Delegato | - |
Lysoclear, Inc.
Lysoclear, Inc. Pharmaceuticals: MajorHealth Technology Lysoclear, Inc. owns and operates pharmaceuticals. It engages in treatment of age-related macular and Stargardt’s macular degeneration. The company is headquartered in Lafayette, NY. | Presidente | - |
Auctus Biologicos, Inc.
Auctus Biologicos, Inc. BiotechnologyHealth Technology Auctus Biologicos, Inc. is a biotechnology company based in Lafayette, NY. The company was founded in 2018 by Aaron Wolfe and Kelsey Moody, with Kelsey Moody serving as the CEO since then. | Amministratore Delegato | 01/01/2018 |
Ichor Therapeutics, Inc.
Ichor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ichor Therapeutics, Inc. is a full-service contract research organization and American longevity biotechnology company. Ichor's CRO services help biotechnology and pharmaceutical companies solve their most difficult challenges, from preclinical studies to late-stage clinical trials and FDA approval, using a personalized approach that puts relationships and science first. As a longevity biotechnology company, Ichor aims to help people live longer, healthier lives by developing therapies with the potential to treat age-related diseases. The private company is pioneering the longevity and anti-aging biotechnology industry while empowering CRO clients to rapidly advance their research and development programs. The company was founded in 2013 in upstate New York and has subsidiaries in the United States. The CEO is Kelsey Moody. | Amministratore Delegato | 01/05/2013 |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Consulente / Consigliere | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 5 |
---|---|
Antoxerene, Inc.
Antoxerene, Inc. BiotechnologyHealth Technology Antoxerene, Inc. operates as a pharmaceutical company. It develops small molecule senolytic drugs for pathways of aging. The company was incorporated in 2016 and is headquartered in Lafayette, NY. | Health Technology |
Methuselah Capital Management LLC
Methuselah Capital Management LLC Investment ManagersFinance Methuselah Capital Management LLC (Methuselah Fund) is a venture capital firm, a subsidiary of Methuselah Foundation founded in 2016 by Sergio Ruiz and David Gobel. The firm is headquartered in Springfield, Virginia. | Finance |
Ichor Therapeutics, Inc.
Ichor Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ichor Therapeutics, Inc. is a full-service contract research organization and American longevity biotechnology company. Ichor's CRO services help biotechnology and pharmaceutical companies solve their most difficult challenges, from preclinical studies to late-stage clinical trials and FDA approval, using a personalized approach that puts relationships and science first. As a longevity biotechnology company, Ichor aims to help people live longer, healthier lives by developing therapies with the potential to treat age-related diseases. The private company is pioneering the longevity and anti-aging biotechnology industry while empowering CRO clients to rapidly advance their research and development programs. The company was founded in 2013 in upstate New York and has subsidiaries in the United States. The CEO is Kelsey Moody. | Commercial Services |
Lysoclear, Inc.
Lysoclear, Inc. Pharmaceuticals: MajorHealth Technology Lysoclear, Inc. owns and operates pharmaceuticals. It engages in treatment of age-related macular and Stargardt’s macular degeneration. The company is headquartered in Lafayette, NY. | Health Technology |
Auctus Biologicos, Inc.
Auctus Biologicos, Inc. BiotechnologyHealth Technology Auctus Biologicos, Inc. is a biotechnology company based in Lafayette, NY. The company was founded in 2018 by Aaron Wolfe and Kelsey Moody, with Kelsey Moody serving as the CEO since then. | Health Technology |
- Borsa valori
- Insiders
- Kelsey Moody